Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-05-19 @ 3:59 AM
Study NCT ID:
NCT05718934
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2022-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
Sponsor:
Ciusss de L'Est de l'Île de Montréal
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2023-3091
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None